Cargando…
Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth
BACKGROUND: Alteration of signalling pathways regulating cell cycle progression is a common feature of cancer cells. Several drugs targeting distinct phases of the cell cycle have been developed but the inability of many of them to discriminate between normal and cancer cells has strongly limited th...
Autores principales: | Cisse, Ouma, Quraishi, Muzthahid, Gulluni, Federico, Guffanti, Federica, Mavrommati, Ioanna, Suthanthirakumaran, Methushaa, Oh, Lara C. R., Schlatter, Jessica N., Sarvananthan, Ambisha, Broggini, Massimo, Hirsch, Emilio, Falasca, Marco, Maffucci, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873561/ https://www.ncbi.nlm.nih.gov/pubmed/31752944 http://dx.doi.org/10.1186/s13046-019-1472-9 |
Ejemplares similares
-
Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion
por: Mavrommati, Ioanna, et al.
Publicado: (2016) -
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
por: Tibolla, Gianpaolo, et al.
Publicado: (2013) -
Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling
por: Maffucci, Tania, et al.
Publicado: (2020) -
Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration
por: Maffucci, Tania, et al.
Publicado: (2005) -
Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy
por: Abbott, J, et al.
Publicado: (2010)